Strategies to increase the donor pool and access to kidney transplantation: An international perspective

Nephrology Dialysis Transplantation

Volumn 30, Issue 2, 2015, Pages 217-222

  Maggiore, Umberto ^a   Oberbauer, Rainer ^b   Pascual, Julio ^c   Viklicky, Ondrej ^d   Dudley, Chris ^e   Budde, Klemens ^f   Sorensen, Soren Schwartz ^g   Hazzan, Marc ^h   Klinger, Marian ⁱ   Abramowicz, Daniel ^j  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HOSPITAL DEL MAR   (Spain)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^e Richard Bright Renal Unit   (United Kingdom)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h UNIV LILLE   (France)

ⁱ WROCLAW MEDICAL UNIVERSITY   (Poland)

^j ANTWERP UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

antibody incompatible kidney transplantation; donation after circulatory death; kidney transplantation; marginal donor; paired donation

Indexed keywords

ECULIZUMAB; HLA ANTIGEN; IMMUNOGLOBULIN; RITUXIMAB;

ANTIBODY MEDIATED REJECTION; BLOOD GROUP ABO INCOMPATIBILITY; CADAVER DONOR; COST EFFECTIVENESS ANALYSIS; DESENSITIZATION; DISEASE ASSOCIATION; DRUG MEGADOSE; EUROPEAN UNION; GLOMERULOPATHY; GRAFT FAILURE; GRAFT SURVIVAL; HLA TYPING; HOSPITALIZATION; HUMAN; IMMUNOADSORPTION; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; RENAL GRAFT DYSFUNCTION; RENAL REPLACEMENT THERAPY; REVIEW; RISK; SURVIVAL RATE; UNITED STATES; DONOR; HEALTH CARE DELIVERY; HEALTH SERVICE; INTERNATIONAL COOPERATION; TRANSPLANTATION;

HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONALITY; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84922582801     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu212     Document Type: Review

References (49)

1. Karpinski M, Knoll G, Cohn A et al. The impact of accepting living kidney donors with mild hypertension or proteinuria on transplantation rates. Am J Kidney Dis 2006; 47: 317-323
2. Takahashi K, Saito K, Takahara S et al. Excellent long-Term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-1096
3. Alexandre GP, Squifflet JP, De Bruyere M et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538-4542
4. Sonnenday CJ, Warren DS, Cooper M et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315-1322
5. Segev DL, Simpkins CE, Warren DS et al. ABO incompatible high-Titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570-2575
6. Genberg H, Kumlien G, Wennberg L et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85: 1745-1754
7. Schnitzler M, Machnicki G. ABO-incompatible living donor transplantation: is it economically "compatible"?. Transplantation 2006; 82: 168-169
8. Barnett AN, Manook M, Nagendran M et al. Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation. Transpl Int 2014; 27: 187-196
9. Morath C, Becker LE, Leo A et al. ABO-incompatible kidney transplantation enabled by non-Antigen-specific immunoadsorption. Transplantation 2012; 93: 827-834
10. Montgomery RA, Lonze BE, King KE et al. Desensitization in HLAincompatible kidney recipients and survival. N Engl J Med 2011; 365: 318-326
11. Sharif A, Kraus ES, Zachary AA et al. Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants. Transplantation 2014; 97: 541-547
12. Bentall A, Cornell LD, Gloor JM et al. Five-year outcomes in living donor kidney transplants with a positive crossmatch. Am J Transplant 2013; 13: 76-85
13. Goodkin DA, Young EW, Kurokawa K et al. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004; 44: 16-21
14. Huber L, Naik M, Budde K. Desensitization of HLA-incompatible kidney recipients. N Engl J Med 2011; 365: 1643. Author reply 1644-1645
15. Stegall MD, Diwan T, Raghavaiah S et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 2011; 11: 2405-2413
16. Raghavaiah S, Gandhi M, Cornell L et al. "Spontaneous" reduction in donor Specific allo-Antibody (DSA) after positive cross match kidney transplantation (+XMKTx) is associated with improved histology. Am J Transplant 2013; 13(S5): 323. Abstr B#986
17. De Klerk M, Witvliet MD, Haase-Kromwijk BJ et al. A flexible national living donor kidney exchange program taking advantage of a central histocompatibility laboratory: the Dutch model. Clin Transpl 2008; 69-73
18. Johnson RJ, Allen JE, Fuggle SV et al. Early experience of paired living kidney donation in the United kingdom. Transplantation 2008; 86: 1672-1677
19. Rees MA, Kopke JE, Pelletier RP et al. A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med 2009; 360: 1096-1101
20. Bingaman AW, Wright FH, Murphey CL. Kidney paired donation in livedonor kidney transplantation. N Engl J Med 2010; 363: 1091-1092
21. Glorie K, Haase-Kromwijk B, Van De Klundert J et al. Allocation and matching in kidney exchange programs. Transpl Int 2014; 27: 333-343
22. Connolly JS, Terasaki PI, Veale JL. Kidney paired donation-The next step. N Engl J Med 2011; 365: 868-869
23. Ferrari P, Hughes PD, Cohney SJ et al. ABO-incompatible matching significantly enhances transplant rates in kidney paired donation. Transplantation 2013; 96: 821-826
24. Montgomery RA, Locke JE, King KE et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009; 87: 1246-1255
25. Li H, Stegall MD, Dean PG et al. Assessing the efficacy of kidney paired donation-performance of an integrated three-site program. Transplantation 2014; doi:10.1097/TP.0000000000000054
26. Huber L, Lachmann N, Durr M et al. Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. Drugs 2012; 72: 1335-1354
27. Claas FH, Witvliet MD, Duquesnoy RJ et al. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. Transplantation 2004; 78: 190-193
28. Doxiadis II, Claas FH. Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization?. We need both. Curr Opin Organ Transplant 2009; 14: 410-413
29. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006; 67: 847-862
30. Becker LE, Susal C, Morath C. Kidney transplantation across HLA and ABO antibody barriers. Curr Opin Organ Transplant 2013; 18: 445-454
31. Eurostam: A European-wide strategy to enhance transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches. available at http://eurostam.eu/page10.html
32. Bartel G, Wahrmann M, Regele H et al. Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Am J Transplant 2010; 10: 2033-2042
33. Vo AA, Peng A, Toyoda M et al. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation 2010; 89: 1095-1102
34. Lobashevsky AL, Higgins NG, Rosner KM et al. Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximab. Transplantation 2013; 96: 182-190
35. Reinsmoen NL, Lai CH, Vo A et al. Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates. Discov Med 2012; 13: 267-273
36. Vo AA, Petrozzino J, Yeung K et al. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab. Transplantation 2013; 95: 852-858
37. Marfo K, Ling M, Bao Y et al. Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients. Transplantation 2012; 94: 345-351
38. Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008; 52: 553-586
39. Waiser J, Schreiber M, Budde K et al. Age-matching in renal transplantation. Nephrol Dial Transplant 2000; 15: 696-700
40. Sung RS, Christensen LL, Leichtman AB et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant 2008; 8: 783-792
41. Tso PL. Access to renal transplantation for the elderly in the face of new allocation policy: a review of contemporary perspectives on 'older' issues. Transplant Rev (Orlando) 2014; 28: 6-14
42. Cecka JM, Cohen B, Rosendale J et al. Could more effective use of kidneys recovered from older deceased donors result in more kidney transplants for older patients?. Transplantation 2006; 81: 966-970
43. Smits JM, Persijn GG, Van Houwelingen HC et al. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant 2002; 2: 664-670
44. Frei U, Noeldeke J, Machold-Fabrizii V et al. Prospective age-matching in elderly kidney transplant recipients-A 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50-57
45. Pierobon ES, Sandrini S, De Fazio N et al. Optimizing utilization of kidneys from deceased donors over 60 years: five-year outcomes after implementation of a combined clinical and histological allocation algorithm. Transpl Int 2013; 26: 833-841
46. Morrissey PE, Monaco AP. Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation 2014; 97: 258-264
47. Dominguez-Gil B, Delmonico FL, Shaheen FA et al. The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation. Transpl Int 2011; 24: 373-378
48. Neyrinck A, Van Raemdonck D, Monbaliu D. Donation after circulatory death: current status. Curr Opin Anaesthesiol 2013; 26: 382-390
49. Johnson RJ, Bradbury LL, Martin K et al. Organ donation and transplantation in the UK-The last decade: a report from the UK national transplant registry. Transplantation 2014; 97(Suppl 1): S1-S27